Cytokinetics (CYTK) Insider Trading & Ownership $38.73 -1.79 (-4.41%) As of 11:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cytokinetics (NASDAQ:CYTK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$20.39 M Get CYTK Insider Trade Alerts Want to know when executives and insiders are buying or selling Cytokinetics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CYTK Insider Buying and Selling by Quarter Remove Ads Cytokinetics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/31/2025Robert I BlumCEOSell15,000$40.75$611,250.00 3/17/2025Andrew CallosEVPSell2,775$44.38$123,154.50 3/17/2025Robert I BlumCEOSell12,648$44.38$561,318.24 3/14/2025Andrew CallosEVPSell100$45.00$4,500.00 3/6/2025Andrew CallosEVPSell3,341$43.27$144,565.07 3/6/2025Robert I BlumCEOSell16,970$43.44$737,176.80 2/18/2025Fady Ibraham MalikEVPSell2,000$45.98$91,960.00 2/4/2025Fady Ibraham MalikEVPSell2,000$48.06$96,120.00 1/21/2025Fady Ibraham MalikEVPSell2,000$45.92$91,840.00 1/7/2025Fady Ibraham MalikEVPSell2,000$49.32$98,640.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/16/2024Wendall WierengaDirectorSell742$48.61$36,068.62 12/11/2024John T HendersonDirectorSell1,780$50.42$89,747.60 12/10/2024Fady Ibraham MalikEVPSell7,300$50.64$369,672.00 12/2/2024Robert I BlumCEOSell5,000$50.76$253,800.00 11/26/2024Fady Ibraham MalikEVPSell7,300$50.16$366,168.00 11/18/2024Robert I BlumCEOSell5,000$50.55$252,750.00 11/12/2024Fady Ibraham MalikEVPSell6,342$58.48$370,880.16 11/1/2024Robert I BlumCEOSell5,000$51.63$258,150.00 10/30/2024Fady Ibraham MalikEVPSell7,300$51.91$378,943.00 10/28/2024Wendall WierengaDirectorSell4,452$52.25$232,617.00 10/15/2024Fady Ibraham MalikEVPSell7,300$54.19$395,587.00 10/9/2024Robert I BlumCEOSell5,000$55.61$278,050.00 10/1/2024Fady Ibraham MalikEVPSell7,300$52.10$380,330.00 9/30/2024Robert I BlumCEOSell5,000$52.14$260,700.00 9/3/2024Fady Ibraham MalikEVPSell7,384$57.01$420,961.84 9/3/2024Robert I BlumCEOSell5,000$57.03$285,150.00 8/12/2024B Lynne ParshallDirectorSell5,000$55.20$276,000.00 8/12/2024Robert I BlumCEOSell11,500$55.17$634,455.00 8/6/2024Fady Ibraham MalikEVPSell7,300$53.71$392,083.00 7/30/2024Robert I BlumCEOSell11,500$59.49$684,135.00 7/29/2024B Lynne ParshallDirectorSell5,000$59.84$299,200.00 7/23/2024Fady Ibraham MalikEVPSell7,300$57.02$416,246.00 7/15/2024B Lynne ParshallDirectorSell5,000$55.82$279,100.00 7/10/2024Robert I BlumCEOSell11,500$54.29$624,335.00 7/9/2024Fady Ibraham MalikEVPSell7,300$55.90$408,070.00 7/5/2024Robert Arthur HarringtonDirectorSell253$54.61$13,816.33 7/1/2024B Lynne ParshallDirectorSell5,000$54.22$271,100.00 7/1/2024Robert I BlumCEOSell11,500$54.05$621,575.00 6/25/2024Fady Ibraham MalikEVPSell7,300$53.72$392,156.00 6/17/2024B Lynne ParshallDirectorSell5,000$52.55$262,750.00 This almost killed Elon Musk (chilling details emerge) (Ad)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro6/17/2024Robert I BlumCEOSell22,500$52.60$1,183,500.00 6/11/2024Fady Ibraham MalikEVPSell7,788$53.04$413,075.52 6/10/2024Muna BhanjiDirectorSell2,000$52.07$104,140.00 6/4/2024Robert I BlumCEOSell22,500$48.85$1,099,125.00 6/3/2024Robert Arthur HarringtonDirectorSell1,580$48.64$76,851.20 6/3/2024Robert WongCAOSell13,011$48.88$635,977.68 5/7/2024Fady Ibraham MalikEVPSell15,547$65.11$1,012,265.17 4/25/2024John T HendersonDirectorSell10,562$64.54$681,671.48 4/9/2024Fady Ibraham MalikEVPSell32,605$74.31$2,422,877.55 (Data available from 1/1/2013 forward) CYTK Insider Trading Activity - Frequently Asked Questions Who is on Cytokinetics's Insider Roster? The list of insiders at Cytokinetics includes Andrew Callos, B Lynne Parshall, Ching Jaw, Fady Ibraham Malik, John T Henderson, Muna Bhanji, Robert Arthur Harrington, Robert I Blum, Robert Wong, and Wendall Wierenga. Learn more on insiders at CYTK. What percentage of Cytokinetics stock is owned by insiders? 3.40% of Cytokinetics stock is owned by insiders. Learn more on CYTK's insider holdings. Which Cytokinetics insiders have been selling company stock? The following insiders have sold CYTK shares in the last 24 months: Andrew Callos ($272,219.57), B Lynne Parshall ($1,388,150.00), Fady Ibraham Malik ($15,606,251.92), John T Henderson ($1,736,868.90), Muna Bhanji ($172,380.00), Robert Arthur Harrington ($90,667.53), Robert I Blum ($17,891,845.04), Robert Wong ($635,977.68), and Wendall Wierenga ($1,197,446.02). How much insider selling is happening at Cytokinetics? Insiders have sold a total of 737,940 Cytokinetics shares in the last 24 months for a total of $38,991,806.66 sold. Cytokinetics Key ExecutivesMr. Robert I. Blum (Age 60)President and Chief Executive Officer Compensation: $1.33M7 recent tradesMr. Robert C. Wong (Age 56)VP & Chief Accounting Officer Compensation: $495.72kDr. Fady Ibraham Malik FACC (Age 60)M.D., Ph.D., Executive Vice President of Research & Development Compensation: $839.66kMr. Andrew M. Callos (Age 55)Executive VP & Chief Commercial Officer Compensation: $752.84k3 recent tradesDr. James A. Spudich Ph.D. (Age 82)Co-Founder & Member of Scientific Advisory Board Compensation: $21.94kMr. Jeff LotzVice President of Sales & OperationsMr. Matt YangVice President of Corporate Finance and Financial Planning & AnalysisMr. Steven M. Cook (Age 65)Senior Vice President of Global Supply Chain Operations & Technical Operations Ms. Kari K. Loeser J.D.VP & Chief Compliance OfficerMr. John O. Faurescu Esq.VP, Associate General Counsel & Corporate Secretary More Insider Trading Tools from MarketBeat Related Companies TEVA Insider Transactions SMMT Insider Transactions ITCI Insider Transactions GMAB Insider Transactions MRNA Insider Transactions VTRS Insider Transactions ROIV Insider Transactions LNTH Insider Transactions BBIO Insider Transactions RVMD Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish This page (NASDAQ:CYTK) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CYTK Stock Free CYTK Stock Alerts